Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

124 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Management of the positive sentinel lymph node following neoadjuvant chemotherapy: results of a survey conducted with breast surgeons.
Cavalcante FP, Zerwes F, Millen EC, Novita G, de Souza ABA, Reis JHP, de Oliveira Filho HR, de B L Limongi LN, de Assis Carvalho BPS, de Oliveira Freitas AM, Jourdan MT, de Oliveira VM, Freitas-Junior R. Cavalcante FP, et al. Ecancermedicalscience. 2022 Feb 18;16:1357. doi: 10.3332/ecancer.2022.1357. eCollection 2022. Ecancermedicalscience. 2022. PMID: 35510139 Free PMC article.
Ipatasertib plus Paclitaxel for Patients with PIK3CA/AKT1/PTEN-Altered Locally Advanced Unresectable or Metastatic Triple-Negative Breast Cancer in the IPATunity130 Phase III Trial.
Dent RA, Kim SB, Oliveira M, Barrios C, O'Shaughnessy J, Isakoff SJ, Saji S, Freitas-Junior R, Philco M, Bondarenko I, Lian Q, Bradley D, Hinton H, Wongchenko MJ, Reilly SJ, Turner N. Dent RA, et al. Among authors: freitas junior r. Clin Cancer Res. 2024 Oct 1;30(19):4329-4338. doi: 10.1158/1078-0432.CCR-24-0465. Clin Cancer Res. 2024. PMID: 39058425 Free PMC article. Clinical Trial.
First-Line Ipatasertib, Atezolizumab, and Taxane Triplet for Metastatic Triple-Negative Breast Cancer: Clinical and Biomarker Results.
Schmid P, Turner NC, Barrios CH, Isakoff SJ, Kim SB, Sablin MP, Saji S, Savas P, Vidal GA, Oliveira M, O'Shaughnessy J, Italiano A, Espinosa E, Boni V, White S, Rojas B, Freitas-Junior R, Chae Y, Bondarenko I, Lee J, Torres Mattos C, Martinez Rodriguez JL, Lam LH, Jones S, Reilly SJ, Huang X, Shah K, Dent R. Schmid P, et al. Clin Cancer Res. 2024 Feb 16;30(4):767-778. doi: 10.1158/1078-0432.CCR-23-2084. Clin Cancer Res. 2024. PMID: 38060199 Free PMC article. Clinical Trial.
Oncoplastic mammaplasty with geometric compensation: Evolution of the technique, outcomes and follow-up in a multicentre retrospective cohort.
Resende Paulinelli R, de Oliveira VM, Bagnoli F, Letzkus Berríos J, Cézar Chade M, Bragatto Picoli L, Dias Santos T, Bastos de Carvalho AP, Jubé Ribeiro LF, Freitas-Junior R. Resende Paulinelli R, et al. J Surg Oncol. 2020 May;121(6):967-974. doi: 10.1002/jso.25860. Epub 2020 Feb 4. J Surg Oncol. 2020. PMID: 32020633
Management of early breast cancer during the COVID-19 pandemic in Brazil.
Cavalcante FP, Novita GG, Millen EC, Zerwes FP, de Oliveira VM, Sousa ALL, Freitas Junior R. Cavalcante FP, et al. Breast Cancer Res Treat. 2020 Nov;184(2):637-647. doi: 10.1007/s10549-020-05877-y. Epub 2020 Aug 16. Breast Cancer Res Treat. 2020. PMID: 32803637 Free PMC article.
Breast reconstruction and coronavirus pandemic.
Cavalcante FP, Novita GG, Millen EC, Zerwes FP, Freitas Junior R. Cavalcante FP, et al. J Plast Reconstr Aesthet Surg. 2021 Mar;74(3):644-710. doi: 10.1016/j.bjps.2020.08.103. Epub 2020 Sep 28. J Plast Reconstr Aesthet Surg. 2021. PMID: 33012691 Free PMC article. No abstract available.
124 results